Caris Life Sciences ® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced ...
EMERALD-3: Phase III trial of IMFINZI ® (durvalumab) in combination with IMJUDO ® (tremelimumab-actl), with or without lenvatinib, and transarterial chemoembolization (TACE) in patients with ...
Agreement with Hangzhou DAC Provides Option for Up to Five New, Internally Developed ADC Programs, Including Dual-Payload ...
As ammonia gains attention as a next-generation energy source capable of overcoming the limits of hydrogen storage and transport, KAIST and a joint research team have developed fuel cell technology ...
Researchers evaluated an allogeneic umbilical cord cell therapy in T1DM. A single dose provided durable insulin preservation, ...
Neurons, the uber-connected nerve cells that act as a main switchboard for the brain, are central to some incredibly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results